Home › Trial NCT04915508
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
- Trial IDNCT04915508
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorJonsson Comprehensive Cancer Center
- Enrollment165
- Start date2021-06-23
- ConditionsProstate Adenocarcinoma · Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 · Stage IIIC Prostate Cancer AJCC v8 · Stage IV Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8 · Stage IVB Prostate Cancer AJCC v8
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.